Ophthalmic Business News

The FDA granted fast track designation to MCO-010 from Nanoscope Therapeutics for the treatment of retinitis pigmentosa.

TC-002, a latanoprost ophthalmic solution, met all primary and secondary endpoints in the phase 3 CLEAR pivotal trial, according to a press release from TearClear.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Victor H. Gonzalez, MD, discusses VisionTEK Automation, an artificial intelligence tool that assists with practice billing and coding.

CHICAGO — In a study aimed at verifying the safety and efficacy of in-office oral sedation for oculofacial surgeries, patients and physicians who used an ASC said postoperatively they would have preferred to be in the office.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Tom Ruggia, president and CEO of Samsara Vision, discusses the ongoing CONCERTO trial investigating the Sing IMT as well as the device’s commercialization around the world.

CHICAGO — In this video from Eyecelerator@AAO, Harrow CEO Mark L. Baum discusses the recent FDA approval of Iheezo for ocular surface anesthesia as well as a new refrigeration-stable fortified antibiotic.

CHICAGO — In this video from Eyecelerator@AAO, Peter Kaiser, MD, discusses data from a phase 1 clinical study investigating OTX-TKI for the treatment of wet age-related macular degeneration.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Opus Genetics CEO Ben Yerxa discusses an upcoming investigational new drug application for OPGx-001.

CHICAGO — Patients with dry age-related macular degeneration experienced sustained improvements in best correct visual acuity at month 13 of the LIGHTSITE III pivotal clinical trial, according to a study presented at Eyecelerator@AAO.

Often, after speaking about taxes at a medical conference, we are approached by a physician attendee who has read that billionaires, like Warren Buffet and Elon Musk, pay less taxes than they do and they wonder how that can be.